News

October 30, 2021
Together with scientist from UCL, we have written a review article covering AI technologies in the field of chronic inflammatory disease.  Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated…
by pierre in Featured  0
September 30, 2021
Check out the latest Covid-19 related publications. SciCross main contributions in these projects has been the design of Sars-CoV-2 peptides used to study T-cell responses.  An evaluation of a FluoroSpot…
by pierre in Featured  0
October 2, 2020
In a collaboration with Novartis, we (SciCross) has developed a method for improved HLA class II binding prediction based on MAPPs data. The results till be presented at the Immunogenicity…
by pierre in Featured  0
August 18, 2020
New paper published in Lancet Rheumatology on immune cell signatures in JSLE patients, discovered by machine learning techniques AND extensive  laboratory work AND clinical knowledge. Really happy to have the…
by pierre in News  0
May 7, 2020
SciCross partners with scientists from Uppsala University, KTH and SciLifeLab in developing Covid-19 treatments in immune suppressed individuals. The project is called “An adaptable therapeutic technology platform to treat SARS-CoV…
by pierre in News  0
December 20, 2019
Great news before Christmas. SciCross is part of a project receiving funding from the Swedish Knowledge Foundation. The project title is “Biomedical AI-driven data analytics” (BIO-AID) and will start in…
by pierre in Uncategorized  0
July 4, 2019
In a recent paper written with colleagues from the ABIRISK consortium we present a study of the genetic risk associated with inhibitor development in patients with severe hemophilia A. #ABIRISK…
by pierre in News  0
May 31, 2019
A recent paper originating from ABIRISK research has been made available online. The paper presents an analysis of retrospective data in European cohort of RA patients treated with adalimumab or…
by pierre in Uncategorized  0